Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Knopf

Showing results (141-150 of 153) with videos related to

Pageof 16
Sort By:
Anticancer Research|July 7, 2021
Health Equity Within Inequity: Timing of Diagnostic Breast Cancer Care in an Underserved Medical PopulationAnnie Tang, Colin M Mooney, Genna Beattie, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 29, 2015
Economic Burden of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid LeukemiaKevin B Knopf, Victoria Divino, Lisa McGarry, et al.
Medical Care|August 21, 2002
Utility of the SEER-Medicare data to identify chemotherapy useJoan L Warren, Linda C Harlan, Angela Fahey, et al.
Journal of Managed Care Pharmacy : JMCP|October 7, 2009
Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancerMichael E Stokes, Catherine E Muehlenbein, Martin D Marciniak, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 16, 2014
Meta-analysis of the efficacy and safety of bortezomib re-treatment in patients with multiple myelomaKevin B Knopf, Mei Sheng Duh, Marie-Hélène Lafeuille, et al.
Cancers|February 13, 2026
Dissecting Context-Specific Effects of ERK5 Signaling in Triple-Negative Breast CancerKatherine L Hebert, Sarah B Knopf, Thomas Cheng, et al.
International Journal of Cancer|February 11, 2020
End of an era for erythropoiesis-stimulating agents in oncologyMartin W Schoen, Shamia Hoque, Bartlett J Witherspoon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2026
WBC Growth Factors: ASCO Guideline UpdateBishal Gyawali, Kari Bohlke, Jana K Dickter, et al.
Journal of Oncology Practice|May 16, 2017
Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced AnemiaVirginia Noxon, Kevin B Knopf, LeAnn B Norris, et al.
Plos One|June 26, 2020
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemiaShamia Hoque, Brian J Chen, Martin W Schoen, et al.
Pageof 16

Showing results (141-150 of 153) with videos related to

Sort By:
Pageof 16
Anticancer Research|July 7, 2021
Health Equity Within Inequity: Timing of Diagnostic Breast Cancer Care in an Underserved Medical PopulationAnnie Tang, Colin M Mooney, Genna Beattie, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 29, 2015
Economic Burden of Tyrosine Kinase Inhibitor Treatment Failure in Chronic Myeloid LeukemiaKevin B Knopf, Victoria Divino, Lisa McGarry, et al.
Medical Care|August 21, 2002
Utility of the SEER-Medicare data to identify chemotherapy useJoan L Warren, Linda C Harlan, Angela Fahey, et al.
Journal of Managed Care Pharmacy : JMCP|October 7, 2009
Neutropenia-related costs in patients treated with first-line chemotherapy for advanced non-small cell lung cancerMichael E Stokes, Catherine E Muehlenbein, Martin D Marciniak, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 16, 2014
Meta-analysis of the efficacy and safety of bortezomib re-treatment in patients with multiple myelomaKevin B Knopf, Mei Sheng Duh, Marie-Hélène Lafeuille, et al.
Cancers|February 13, 2026
Dissecting Context-Specific Effects of ERK5 Signaling in Triple-Negative Breast CancerKatherine L Hebert, Sarah B Knopf, Thomas Cheng, et al.
International Journal of Cancer|February 11, 2020
End of an era for erythropoiesis-stimulating agents in oncologyMartin W Schoen, Shamia Hoque, Bartlett J Witherspoon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 25, 2026
WBC Growth Factors: ASCO Guideline UpdateBishal Gyawali, Kari Bohlke, Jana K Dickter, et al.
Journal of Oncology Practice|May 16, 2017
Tale of Two Erythropoiesis-Stimulating Agents: Utilization, Dosing, Litigation, and Costs of Darbepoetin and Epoetin Among South Carolina Medicaid-Covered Patients With Cancer and Chemotherapy-Induced AnemiaVirginia Noxon, Kevin B Knopf, LeAnn B Norris, et al.
Plos One|June 26, 2020
End of an era of administering erythropoiesis stimulating agents among Veterans Administration cancer patients with chemotherapy-induced anemiaShamia Hoque, Brian J Chen, Martin W Schoen, et al.
Pageof 16